Functional Brands Inc (NASDAQ: MEHA) is a consumer health company that develops and sells dietary supplements and nutraceutical products. Revenue comes from direct-to-consumer sales of supplement products and, as of FY2025, from a telehealth and wellness platform called Tru2u.health that pairs board-certified clinical support with personalized treatment plans and the company's nutraceutical portfolio. The company operates in the U.S. dietary supplement market, which Grand View Research valued at approximately $68.7 billion in 2025. Products are manufactured at an FDA-registered, cGMP-compliant facility. The Tru2u.health platform is structured for nationwide patient onboarding and uses digital acquisition and external influencers for consumer reach. CEO Eric Gripentrog received total compensation of $1,086,666 in FY2025, including $500,000 in restricted stock units tied to a NASDAQ listing milestone. CFO Tariq Rahim received $200,000 in FY2025 salary. The company has issued Series A and Series B convertible preferred stock, carries convertible debt instruments, and relies on equity-linked financing.

Revenue model

Direct-to-consumer sales of dietary supplement and nutraceutical products, supplemented by a telehealth and wellness platform (Tru2u.health) intended to generate recurring revenue through personalized treatment plans and ongoing supplement subscriptions. Specific revenue figures by segment are not disclosed in the excerpts.

Products and services

Dietary supplements and nutraceuticals including essential fatty acids, oxytocin, vitamin B12, vitamin B6 and magnesium, glutathione, melatonin, amino acids, probiotics, multivitamins and minerals, digestive enzymes, antioxidants, and supplements for autism. Also operates Tru2u.health, a consumer-facing telehealth and wellness platform combining clinical oversight with supplement and medication-based therapies.

Customers and end markets

Direct-to-consumer health and wellness buyers in the United States. End markets include general wellness, preventive healthcare, fitness, mental well-being, immune support, and maternal and prenatal health. The Tru2u.health platform targets patients nationwide across applicable state telehealth jurisdictions.

Value-chain role

Brand owner and direct-to-consumer seller. Manufacturing is outsourced to an FDA-registered, cGMP-compliant third-party facility. The company handles product development, packaging, labeling, marketing, and digital distribution. Telehealth services are delivered through a commercial services agreement with CareVali (as referenced in the filing).

Geographic exposure

United States, with Tru2u.health structured for nationwide patient onboarding in compliance with state telehealth regulations. No international operations are disclosed in the excerpts.

Source: SEC 10-K, filed 2026-03-27

Industry: Medicinal Chemicals & Botanical Products